Clinical Impact of Tumor Regression Grade after Preoperative Chemoradiation for Locally Advanced Rectal Cancer: Subset Analyses in Lymph Node Negative Patients

다국어 초록 (Multilingual Abstract)

Background: We investigated the prognostic significance of tumor regression grade (TRG) after preoperative chemoradiation therapy (preop-CRT) for locally advanced rectal cancer especially in the patients without lymph node metastasis.
Methods: One-hundred seventy-eight patients who had cT3/4 tumors were given 5,040 cGy preoperative radiation with 5-fluorouracil/leucovorin chemotherapy. A total mesorectal excision was performed 4-6 weeks after preop-CRT. TRG was defined as follows: grade 1 as no cancer cells remaining; grade 2 as cancer cells outgrown by fibrosis; grade 3 as a minimal presence or absence of regression. The prognostic significance of TRG in comparison with histopathologic staging was analyzed.
Results: Seventeen patients (9.6%) showed TRG1. TRG was found to be significantly associated with cancer-specific survival (CSS; P = 0.001) and local recurrence (P = 0.039) in the univariate study, but not in the multivariate analysis. The ypN stage was the strongest prognostic factor in the multivariate analysis. Subgroup analysis revealed TRG to be an independent prognostic factor for the CSS of ypN0 patients (P = 0.031). TRG had a stronger impact on the CSS of ypN (-) patients (P = 0.002) than on that of ypN (+) patients (P = 0.521). In ypT2N0 and ypT3N0, CSS was better for TRG2 than for TRG3 (P = 0.041, P = 0.048), and in ypN (-) and TRG2 tumors, CSS was better for ypT1-2 than for ypT3-4 (P = 0.034).
Conclusion: TRG was found to be the strongest prognostic factor in patients without lymph node metastasis (ypN0), and different survival was observed according to TRG among patients with a specific histopathologic stage. Thus, TRG may provide an accurate prediction of prognosis and may be used for f tailoring treatment for patients without lymph node metastasis.

참고문헌 (Reference)

1 Caricato M, "Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer" 33 : 724-728, 2007

2 Janjan NA, "Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience" 44 : 1027-1038, 1999

3 Vecchio FM, "The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer" 62 : 752-760, 2005

4 Willett CG, "Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation" 32 : 57-61, 1995

5 Wheeler JM, "Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system" 45 : 1051-1056, 2002

6 Rodel C, "Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer" 23 : 8688-8696, 2005

7 Janjan NA, "Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer" 51 : 153-160, 1999

8 Sauer R, "Preoperative versus postoperative chemoradiotherapy for rectal cancer" 351 : 1731-1740, 2004

9 Kim NK, "Preoperative staging of rectal cancer with MRI: accuracy and clinical usefulness" 7 : 732-737, 2000

10 Valentini V, "Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation" 40 : 1067-1075, 1998

11 Ryan R, "Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer" 47 : 141-146, 2005

12 Dworak O, "Pathological features of rectal cancer after preoperative radiochemotherapy" 12 : 19-23, 1997

13 Mandard AM, "Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations" 73 : 2680-2686, 1994

14 "Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival" 244 (244): 1024-1030, 2006

15 Read TE, "Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status" 47 : 825-831, 2004

16 Onaitis MW, "Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience" 233 : 778-785, 2001

17 Glehen O, "Lyons Oncology Group. Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer" 90 : 996-998, 2003

18 Ruo L, "Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy" 236 : 75-81, 2002

19 Kim DW, "Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer" 106 : 1694-1700, 2006

20 Klautke G, "Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer" 92 : 1215-1220, 2005

21 Francois Y, "Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter- sparing surgery for rectal cancer: the Lyon R90-01 randomized trial" 17 : 2396-, 1999

22 Gerard JP, "Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial" 22 : 2404-2409, 2004

23 Janjan NA, "Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer" 24 : 107-112, 2001

24 Bouzourene H, "Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy" 94 : 1121-1130, 2002

25 Valentini V, "Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients" 53 : 664-674, 2002

26 Bosset JF, "Chemotherapy with preoperative radiotherapy in rectal cancer" 355 : 1114-1123, 2006

27 De Paoli A, "Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study" 17 : 246-251, 2006

28 Greene FL, "AJCC cancer staging manual" Springer- Verlag 2002